Arcturus Therapeutics and CSL’s Kostaive COVID-19 vaccine approved in Europe
CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a ...
Business Wire3d
HealthBio™ Therapeutics Begins FDA-Approved Fast-Track Clinical Trial for Treatment of Long COVID with a Patented Combination of Maraviroc and Atorvastatin
and continue to experiment with the extended use of therapeutics originally developed to treat the COVID-19 infection, which show mixed results. Additionally, the Centers for Disease Control and ...
CSL, Arcturus Therapeutics announce European Commission approval for Kostaive
CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a ...
cidrap.umn4d
Data: Despite high risk of poor outcomes, only 1% of pregnant COVID patients given antiviral
The rate of antiviral prescriptions was 67% lower in pregnant than in nonpregnant women, including those with 1 or more ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Nature2y
mRNA vaccines and treatments: beyond COVID-19
The COVID-19 pandemic has triggered an unprecedented mobilization of resources to find vaccines and therapeutics to treat and prevent infection with SARS-CoV-2. mRNA technology was quickly adopted ...
Arcturus Therapeutics' SWOT analysis: mRNA innovator's stock faces pivotal year
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...
CBC.ca19d
CIA believes COVID-19 most likely originated from a lab but has low confidence in its own finding
The CIA now believes the virus responsible for the COVID-19 pandemic most likely originated from a laboratory, according to an assessment released Saturday that points the finger at China even ...
Medical Xpress on MSN9d
New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...